Overview

A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
A double-blind, placebo-controlled, randomized, parallel-group study to evaluate the activity of oral AB1010 in adults patients with moderate to severe chronic plaque psoriasis
Phase:
Phase 2
Details
Lead Sponsor:
AB Science